Clinical Trials Directory

Trials / Completed

CompletedNCT01828931

Lifestyle Intervention for Diabetes and Weight Management in Psychosis

Effectiveness of Intensive Lifestyle Interventions in the Management of Diabetes in Individuals With Psychosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The rate of type-2 diabetes mellitus (T2DM) is at least 2-3 times higher in persons with psychotic illnesses than in the general population. Life expectancy of individuals with psychosis is also 20-25 years less than the general population, primarily due to premature onset of cardiovascular disease (CVD). Despite the high risk for T2DM and CVD, psychotic illness has been an exclusion criterion in all large-scale studies of diabetes prevention and management. We propose a 3-year randomized controlled trial examining the effectiveness of a lifestyle intervention (LI) aimed at reducing caloric intake and increasing physical activity in overweight or obese individuals (N=150) suffering from both a psychotic illness and T2DM. Weight and glycemic control will be the primary outcome variables. It is hypothesized that a significant weight reduction and improvement in glycemic control will be found in those who receive the LI relative to those who do not.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLifestyle InterventionA lifestyle intervention (LI) aimed at reducing caloric intake and increasing physical activity
OTHERUsual CareCare as usual

Timeline

Start date
2012-12-01
Primary completion
2015-05-01
Completion
2015-11-01
First posted
2013-04-11
Last updated
2016-06-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01828931. Inclusion in this directory is not an endorsement.